|
Research and Markets: the Asthma, COPD & Allergic Rhinitis Market Outlook to …
Business Wire (press release) The global respiratory market was valued at $44.0bn in sales in 2010 with asthma/COPD drugs being the key revenue drivers of the therapeutic segment. Of respiratory indications, asthma represents the main area of R&D interest for pharmaceutical … |
View full post on asthma – Google News